PFM Health Sciences, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001442756

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q2 2024 · 76 positions · Total reported value $1.97B · Top-10 concentration 47.3% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 75.8% · 24 new · 28 cut · 39 exited

Active Share (vs S&P 500): 96.6% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -4.9% · vs SPY -7.0% · Prev Value $1.14B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +2.3% · vs SPY +0.2% · Latest Value $978.49M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q2 2024 13F filing, PFM Health Sciences, LP disclosed 76 equity positions with a combined reported value of $1.97B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 47.3% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2024 were LLY ($270.39M), CYTK ($95.20M), QQQ ($89.79M). By sector, the heaviest allocations are Health Care 84.2%, Industrials 3.8%. Versus the prior quarter, allocation shifted toward Health Care (+3.9pp) and away from Technology (-1.4pp), Industrials (-2.2pp).

Versus the prior quarter, PFM Health Sciences, LP opened 24 new positions, trimmed 28 and fully exited 39, a turnover rate of 75.8% of positions. The portfolio's overlap with the prior quarter was 78% of names.

The largest new positions opened in Q2 2024 were QQQ ($89.79M), XBI ($55.12M), AMGN ($25.32M).

Of the 39 positions fully exited versus the prior quarter, the largest were TLT ($49.49M), LEGN ($41.19M), ZBH ($39.64M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2024)

  • QQQ INVESCO QQQ TR · $89.79M
  • XBI SPDR SERIES TRUST · $55.12M
  • AMGN AMGEN INC · $25.32M
  • JNJ JOHNSON & JOHNSON · $18.83M
  • INSM INSMED INC · $16.17M
  • KROS KEROS THERAPEUTICS INC · $1.52M
  • WAY WAYSTAR HLDG CORP · $752.50K

Fully Exited (vs previous quarter)

  • TLT ISHARES TR · prev qtr: $49.49M
  • LEGN LEGEND BIOTECH CORP · prev qtr: $41.19M
  • ZBH ZIMMER BIOMET HOLDINGS INC · prev qtr: $39.64M · history
  • AVTR AVANTOR INC · prev qtr: $34.35M
  • FXI ISHARES TR · prev qtr: $28.02M
  • VEEV VEEVA SYS INC · prev qtr: $27.55M · history
  • WST WEST PHARMACEUTICAL SVSC INC · prev qtr: $20.26M
  • ARKK ARK ETF TR · prev qtr: $12.13M

Insider Transactions (Form 4)

Latest PFM Health Sciences, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

PFM Health Sciences, LP is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q2 2026 it reported 96 US equity positions with a combined value of $1.14B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-69012 (status: Approved), registered 2008-04-10
  • Regulatory AUM (Form ADV): $1.27B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 4 private funds, of which 2 hedge funds
  • Website: pfmhealthsciences.com

Portfolio Structure

  • 96 positions · $1.14B reported value (Q2 2026)
  • Top 10 holdings = 34.6% of reported value
  • Largest position: ASND (ASCENDIS PHARMA A/S) at 5.4%
  • Average position size: $11.89M

Sector Tilt

  • Health Care 92.9%
  • Industrials 5.1%
  • Consumer Staples 1.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 32 new, 24 added, 40 reduced, 14 exited

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 84.2%
Materials 0.5%
Technology 0.0%
Other 11.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 298.64K $270.39M 13.71%
13.71%
Hold
2 1.76M $95.20M 4.83%
4.83%
Reduce
3 187.40K $89.79M 4.55%
4.55%
New
4 589.41K $78.41M 3.98%
3.98%
Hold
5 596.26K $73.82M 3.74%
3.74%
Hold
6 148.85K $69.77M 3.54%
3.54%
Hold
7 403.86K $69.27M 3.51%
3.51%
Hold
8 740.26K $68.38M 3.47%
3.47%
Hold
9 137.33K $61.09M 3.10%
3.10%
Add
10 97.50K $56.94M 2.89%
2.89%
Hold
11 594.50K $55.12M 2.80%
2.80%
New
12 125.34K $46.83M 2.38%
2.38%
Hold
13 124.84K $40.11M 2.03%
2.03%
Add
14 598.51K $39.68M 2.01%
2.01%
Hold
15 213.98K $39.57M 2.01%
2.01%
Hold
16 114.30K $38.89M 1.97%
1.97%
Add
17 467.43K $37.63M 1.91%
1.91%
Hold
18 86.83K $37.34M 1.89%
1.89%
Hold
19 116.53K $36.53M 1.85%
1.85%
Add
20 63.65K $35.20M 1.78%
1.78%
Add
21 185.11K $33.31M 1.69%
1.69%
Add
22 125.52K $31.36M 1.59%
1.59%
Hold
23 131.38K $30.70M 1.56%
1.56%
Reduce
24 55.25K $29.94M 1.52%
1.52%
Hold
25 420.16K $28.38M 1.44%
1.44%
Add
26 348.11K $26.81M 1.36%
1.36%
Add
27 52.40K $26.69M 1.35%
1.35%
Add
28 231.01K $26.19M 1.33%
1.33%
Add
29 81.03K $25.32M 1.28%
1.28%
New
30 111.85K $23.65M 1.20%
1.20%
Hold
31 70.09K $20.84M 1.06%
1.06%
Hold
32 18.00M $20.10M 1.02%
1.02%
Add
33 128.82K $18.83M 0.95%
0.95%
New
34 453.15K $18.74M 0.95%
0.95%
Reduce
35 311.98K $17.22M 0.87%
0.87%
Add
36 241.31K $16.17M 0.82%
0.82%
New
37 2.97M $15.60M 0.79%
0.79%
Reduce
38 15.00M $14.91M 0.76%
0.76%
Hold
39 70.70K $14.34M 0.73%
0.73%
Reduce
40 837.00K $13.71M 0.69%
0.69%
Add
41 860.82K $13.62M 0.69%
0.69%
Hold
42 472.54K $12.48M 0.63%
0.63%
Hold
43 170.40K $11.67M 0.59%
0.59%
Add
44 4.67M $11.03M 0.56%
0.56%
Add
45 10.52M $10.26M 0.52%
0.52%
Add
46 7.75M $9.99M 0.51%
0.51%
Add
47 29.97K $8.40M 0.43%
0.43%
Hold
48 387.36K $7.95M 0.40%
0.40%
Reduce
49 3.24M $7.91M 0.40%
0.40%
Add
50 4.08M $6.70M 0.34%
0.34%
Reduce

FAQ

What did PFM Health Sciences, LP buy in 2024-Q2?

In its 2024-Q2 13F filing, PFM Health Sciences, LP reported 76 equity positions worth $1.97B in aggregate; its largest disclosed positions were LLY ($270.39M), CYTK ($95.20M), QQQ ($89.79M).

How large is PFM Health Sciences, LP's portfolio?

PFM Health Sciences, LP reported $1.97B of long equity holdings across 76 positions as of 2024-Q2. Top-10 holdings account for 47.3% of reported value.

What is PFM Health Sciences, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/pfm-health-sciences/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →